ArticleFrontiers in immunology2022

CRISPR/Cas9 based blockade of IL-10 signaling impairs lipid and tissue homeostasis to accelerate atherosclerosis.

Haozhe Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.